197 related articles for article (PubMed ID: 9358661)
21. Thrombolytic failure with streptokinase in acute myocardial infarction using electrocardiogram criteria.
Lee YY; Tee MH; Zurkurnai Y; Than W; Sapawi M; Suhairi I
Singapore Med J; 2008 Apr; 49(4):304-10. PubMed ID: 18418522
[TBL] [Abstract][Full Text] [Related]
22. [Fibrinolysis and hemorrhage after streptokinase in acute myocardial infarct].
Cassin M; Charmet PA; Rellini G; Molaro G; Bitto S; Brieda M; Zanuttini D
G Ital Cardiol; 1987 Jul; 17(7):601-4. PubMed ID: 3678711
[TBL] [Abstract][Full Text] [Related]
23. [Streptokinase as routine treatment in acute myocardial infarction. The effect on pain, arrhythmias and mortality assessed by a historical cohort study].
Christensen JH; Sørensen HT; Nielsen FE; Ravn L; Rasmussen SE
Ugeskr Laeger; 1991 Dec; 153(49):3473-6. PubMed ID: 1776180
[TBL] [Abstract][Full Text] [Related]
24. [The treatment of myocardial infarct with streptokinase].
Valere PE; Tricot R
Ann Anesthesiol Fr; 1978; 19(8):727-33. PubMed ID: 31117
[TBL] [Abstract][Full Text] [Related]
25. Platelet-activating factor antagonism and streptokinase-induced hypotension in clinical acute myocardial infarction.
Taylor R; Fatovich D; Hitchcock T; Morrison C; Curtis L
Clin Sci (Lond); 2001 Jun; 100(6):601-7. PubMed ID: 11352774
[TBL] [Abstract][Full Text] [Related]
26. Effect of streptokinase on reperfusion after acute myocardial infarction and its complications: an ex-post facto study.
Taheri L; Boroujeni AZ; Kargar Jahromi M; Charkhandaz M; Hojat M
Glob J Health Sci; 2015 Jan; 7(4):184-9. PubMed ID: 25946921
[TBL] [Abstract][Full Text] [Related]
27. Streptokinase and enoxaparin in the pre-hospital management of the ST-segment elevation acute myocardial infarction.
Tatu-Chiţoiu G; Oprişan M; Cismara O; Marinescu R; Marinescu A
Rom J Intern Med; 2002; 40(1-4):11-25. PubMed ID: 15526537
[TBL] [Abstract][Full Text] [Related]
28. Megadose heparin and streptokinase produce similar TIMI 3 flow at discharge in patients of acute myocardial infarction presenting between 7-12 hours.
Dwivedi SK; Pramod K; Gupta R; Saran RK; Narain VS; Puri VK
Indian Heart J; 2000; 52(2):183-6. PubMed ID: 10893895
[TBL] [Abstract][Full Text] [Related]
29. [Clinical picture of acute myocardial infarction depending on the use of pharmacologic treatment schemes].
Jankowska A; Sarachman K; Drozd J; Palusiński R; Kudlicki J
Wiad Lek; 1995; 48(1-12):175-9. PubMed ID: 9638235
[TBL] [Abstract][Full Text] [Related]
30. [Streptokinase in acute myocardial infarction].
Malmcrona R; Ryttberg B; Stjerna A
Lakartidningen; 1985 Nov; 82(48):4212-4. PubMed ID: 4079605
[No Abstract] [Full Text] [Related]
31. Inhibitors of the kinin system as an alternative method of prevention or reduction reperfusive damages within thrombolytic therapy in patients with acute myocardium infarction.
Korotkov A; Kistauri A; Korotkova A; Jibladze M; Guchua E
Georgian Med News; 2006 Nov; (140):54-62. PubMed ID: 17179590
[TBL] [Abstract][Full Text] [Related]
32. Predictors of intracranial hemorrhage with fibrinolytic therapy in unselected community patients: a report from the FASTRAK II project.
Huynh T; Cox JL; Massel D; Davies C; Hilbe J; Warnica W; Daly PA;
Am Heart J; 2004 Jul; 148(1):86-91. PubMed ID: 15215796
[TBL] [Abstract][Full Text] [Related]
33. Intracoronary thrombolytic (streptokinase) therapy of acute myocardial infarction in a community hospital; report of eleven consecutive cases.
Mackie RW; Freeman DJ
Wis Med J; 1983 Jan; 82(1):15-7. PubMed ID: 6829188
[No Abstract] [Full Text] [Related]
34. Excess heparin dosing among fibrinolytic-treated patients with ST-segment elevation myocardial infarction.
Wang TY; Chen AY; Alexander KP; Ohman EM; Gibler WB; Peterson ED; Roe MT
Am J Med; 2008 Sep; 121(9):805-10. PubMed ID: 18724971
[TBL] [Abstract][Full Text] [Related]
35. [Death after ST-elevation myocardial infarction in patients treated with fibrinolytic therapy, angioplasty, or conventional therapy. A post-mortem study to verify cardiac rupture as a cause of death].
Fornaro G; Lazzero M; Giacalone A; Aralda D; Prando MD; Rossi L; Bongo AS
G Ital Cardiol (Rome); 2008 Jun; 9(6):408-20. PubMed ID: 18681392
[TBL] [Abstract][Full Text] [Related]
36. [Use of heparin in acute myocardial infarction in routine clinical practice in Germany. Results of the MITRA and MIR registries].
Frilling B; Schiele R; Zahn R; Fischer F; Schneider S; Gitt AK; Heer T; Gottwik M; Glunz HG; Gieseler U; Baumgärtel B; Asbeck F; Senges J;
Z Kardiol; 2002 Feb; 91(2):131-8. PubMed ID: 11963730
[TBL] [Abstract][Full Text] [Related]
37. [Practical experiences with routine streptokinase treatment in acute myocardial infarction].
Jensen G; Nielsen JD; Hildebrandt P; Christiansen I
Ugeskr Laeger; 1988 Jul; 150(30):1839-41. PubMed ID: 3413854
[No Abstract] [Full Text] [Related]
38. Decision support and the appropriate use of fibrinolysis in myocardial infarction.
Kellett J
Eff Clin Pract; 2001; 4(1):1-9. PubMed ID: 11234180
[TBL] [Abstract][Full Text] [Related]
39. Double bolus of 0.75 MU streptokinase plus enoxaparin versus front-loaded alteplase plus unfractionated heparin in ST-segment elevation myocardial infarction.
Tatu-Chiţoiu G; Teodorescu C; Dan M; Căpraru P; Guran M; Istrătescu O; Tatu-Chiţoiu A; Bumbu A; Dorobanţu M
Rom J Intern Med; 2003; 41(4):395-408. PubMed ID: 15526522
[TBL] [Abstract][Full Text] [Related]
40. [Influence of systemic arterial hypertension on mid-term survival of patients with acute myocardial infarction treated with fibrinolytic agents].
Martínez Sande JL; González-Juanatey JR; García-Acuña JM; Amaro Cendón A; Fernández Vázquez F; Fernández López JA; García Seara J; Vega Fernández JM; López Lago A; Gil de la Peña M
Med Clin (Barc); 1997 Oct; 109(14):532-7. PubMed ID: 9580043
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
